The Procter & Gamble Company, a global consumer goods maker with products sold in about 180 countries, reports an aggregate market value of voting stock held by non‑affiliates of $333 billion as of December 31, 2025 and 2,324,433,060 common shares outstanding as of July 31, 2026.
The company is executing significant portfolio and productivity actions. A limited market portfolio restructuring, including substantial liquidation of operations in Argentina, led to incremental after‑tax restructuring charges of $1.2 billion. Separately, an indefinite‑lived Gillette intangible was written down by $1.3 billion before tax ($1.0 billion after tax). A newer plan announced in June 2025 targets $1.5–$2.0 billion in before‑tax restructuring costs over two years and a reduction of up to 7,000 non‑manufacturing roles by fiscal 2027.
Capital allocation remains shareholder‑focused: in fiscal 2026 P&G completed a $5 billion share repurchase plan and paid a dividend for the 136th consecutive year, marking 70 straight years of increases and a 10‑year dividend CAGR of 5%. The company realized a $261 million after‑tax gain as Clorox purchased P&G’s Glad joint‑venture interest for $476 million, and it is recovering approximately half of about $200 million in previously paid U.S. IEEPA tariffs. Human capital is sizable, with roughly 104,000 employees as of June 30, 2026, down 4% year over year amid restructuring.
Procter & Gamble Co. is having its 3.250% Notes due 2026 removed from listing and registration on the New York Stock Exchange LLC under Section 12(b) of the Securities Exchange Act of 1934.
The New York Stock Exchange certifies that it has complied with its rules to strike this class of securities from listing and/or withdraw registration pursuant to 17 CFR 240.12d2-2(b). The issuer is stated to have complied with the Exchange’s rules and the requirements of 17 CFR 240.12d2-2(c) governing voluntary withdrawal of the class of securities from listing and registration.
The Procter & Gamble Company reported fiscal 2026 results showing modest growth in a tougher environment. Organic sales grew 1%, with flat volumes and 1 point of pricing, and 9 of 10 categories plus all 7 regions held or grew organic sales. Core EPS was $6.89, up 1%, while currency-neutral Core EPS was $6.80, in line with the prior year. Adjusted free cash flow productivity reached 100%, supported by operating cash flow of $19,556 million and adjusted free cash flow of $15,835 million.
Fourth quarter trends were softer: organic sales were flat and Core EPS of $1.43 declined 3% year over year, with currency-neutral Core EPS down 5%. For the year, Core gross and operating margins compressed by 40 and 70 basis points, respectively. For fiscal 2027, management guides to 1%–3% organic and net sales growth, 0%–3% Core EPS growth, all-in EPS growth of 1%–5%, adjusted free cash flow productivity of 85%–90%, a Core effective tax rate of about 20%, and plans for more than $10 billion in dividends and approximately $5 billion of share repurchases.
The Procter & Gamble Company announced a planned leadership transition. Executive Chairman Jon R. Moeller will retire as Executive Chairman and as a member of the Board of Directors effective July 31, 2026, and will retire from the company on August 14, 2026, after 38 years of service.
Shailesh G. Jejurikar, currently President, Chief Executive Officer and a director, has been appointed Chairman of the Board effective August 1, 2026, in addition to his existing responsibilities, to serve at the pleasure of the Board. The non-employee directors also reappointed Joseph Jimenez as the Board’s independent Lead Director. A news release dated July 29, 2026 announcing these changes is furnished as an exhibit. Procter & Gamble notes its portfolio of leading consumer brands and operations in approximately 70 countries worldwide.
The Procter & Gamble Company reported results for the fourth quarter and fiscal year ended June 30, 2026 and provided fiscal 2027 guidance. Fiscal 2026 net sales were $87.0 billion, up 3%, with organic sales up 1%. Diluted EPS was $6.62, up 2%, and core EPS was $6.89, up 1%. Operating cash flow reached $19.6 billion and adjusted free cash flow productivity was 100%. The company returned over $15 billion to shareholders, including $10.2 billion in dividends and $5.0 billion in share repurchases.
In the June 2026 quarter, net sales were $21.2 billion, up 2%, while diluted EPS declined 15% to $1.26 and core EPS declined 3% to $1.43, as higher SG&A and lower gross margin pressured profitability. Gross margin for the year fell 100 bps to 50.2% and operating margin fell 160 bps to 22.7%. For fiscal 2027, P&G guides all-in and organic sales growth of 1%–3% and diluted EPS growth of 1%–5%, with core EPS expected between $6.89 and $7.11. The company plans around $10 billion in dividends and approximately $5 billion of share repurchases in fiscal 2027.
The Procter & Gamble Company declared a quarterly dividend of $1.0885 per share on its Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock. The dividend is payable on or after August 17, 2026.
Common Stock shareowners of record at the close of business on July 24, 2026 and ESOP Convertible Class A Preferred shareowners of record at the start of business on July 24, 2026 will be eligible. P&G reports it has paid dividends for 136 consecutive years and increased its dividend for 70 consecutive years, underscoring its focus on returning cash to shareowners.
PROCTER & GAMBLE Co executive Juliana Monteiro Santos de Azevedo, CEO – Grooming, reports her beneficial ownership of company equity. She holds 19,361.8513 shares of Common Stock directly and 331.2100 shares indirectly through an International Stock Ownership Plan & Pension Plan. She also holds multiple awards of Restricted Stock Units that can deliver P&G common stock or cash, and several stock options (rights to buy) Common Stock, including options over 17,440 shares at an exercise price of $156.83 expiring in 2035 and 36,482 shares at $153.18 expiring in 2035. Footnotes explain that certain RSUs are retirement awards and dividend equivalents that represent contingent rights to receive P&G common stock or cash based on the company’s retirement program formulas.
PROCTER & GAMBLE Co executive Juliana Monteiro Santos de Azevedo, CEO – Grooming, reported her initial beneficial ownership on a Form 3. She directly holds 19,361.8513 shares of common stock and indirectly holds 331.2100 shares through an International Stock Ownership Plan & Pension Plan. She also holds multiple grants of Restricted Stock Units that can settle in common stock or cash and several stock options to buy common shares at exercise prices between $128.5100 and $174.0800 with expirations from 2032-10-01 to 2035-10-01.
PROCTER & GAMBLE Co director Robert Jones Portman received 51 shares of common stock as a stock award. The award was reported at a price of $0.00 per share and represents Restricted Stock Units granted under The Procter & Gamble 2025 Stock and Incentive Compensation Plan.
Footnotes state the total reported amount includes dividend equivalents granted in the form of additional Restricted Stock Units. After this compensation-related acquisition, Portman’s directly held position increased to about 5,155.4641 shares, reflecting a routine equity grant rather than an open-market purchase.
McEvoy Ashley reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co director Ashley McEvoy received an equity award of 202 shares of Common Stock-equivalent Restricted Stock Units. The award was granted at no cash cost under The Procter & Gamble 2025 Stock and Incentive Compensation Plan and includes dividend equivalents paid in additional Restricted Stock Units. Following this grant, McEvoy directly holds a total of 5,986.2484 shares of Procter & Gamble common stock, reflecting a routine compensation-related increase in equity ownership rather than an open-market purchase.